ANNA RICHO

CIK 1199306 · SVP & CCO · last filed 2026-05-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$19.93M

Companies

4

Total Filings

51

Lifetime Open-Market Net

-$8.53M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ILMN Director 8,527 $160.97 $1.37M $0 3 2026-05-22
EXCw Director 11,337 $0 12 2026-04-29
Adamas Pharmaceuticals Inc (ADMS) Delisted Director 0 $8.22 $0 $0 3 2021-11-24
AMGN SVP & CCO 52,248 $355.20 $18.56M -$8.53M 33 2012-08-01

Recent Filings · Page 5 of 6

51 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2010-02-24 AMGN Sell (S) −450 -$25.7K EDGAR
2009-11-06 AMGN Mixed −2,000 -$107.2K EDGAR
2009-07-31 AMGN Tax (F) −894 -$56.4K EDGAR
2009-05-22 AMGN Sell (S) −2,500 -$124.4K EDGAR
2009-05-08 AMGN Mixed +1,495 -$39.6K EDGAR
2009-05-01 AMGN Tax (F) −302 -$15.2K EDGAR
2009-04-30 AMGN Grant (A) +5,700 $0 EDGAR
2009-03-05 AMGN Sell (S) −4,400 -$241.3K EDGAR
2009-03-04 AMGN Sell (S) −4,400 -$241.3K EDGAR
2008-10-27 AMGN Sell (S) −4,400 -$241.3K EDGAR
Showing 4150 of 51
Page 5 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.